skip to main content

Labetalol Alpha-Beta Blocker — FRCA Primary MCQ

Instant feedback + full explanation. One question, done properly.

HardPharmacology - CardiovascularLabetalol Alpha-Beta BlockerFRCA Primary

Which pharmacodynamic property distinguishes labetalol from propranolol in the treatment of hypertension?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: AAlpha-1 blockade combined with non-selective beta-adrenoceptor blockade

The best answer is “Alpha-1 blockade combined with non-selective beta-adrenoceptor blockade”. Labetalol combines alpha-1 blockade, which reduces arteriolar resistance, with non-selective beta blockade, which limits reflex sympathetic cardiac stimulation. Propranolol is a non-selective beta blocker without alpha-1 blockade. The UK SmPC describes this combined mechanism and its relevance to hypertension, including pregnancy and controlled hypotension.

Reference: Labetalol injection, UK Summary of Product Characteristics: https://www.medicines.org.uk/emc/product/10155/smpc